The global antiemetics drugs market was valued at USD 3.1 billion in 2022, growing at a CAGR of 5.9% from 2023 to 2032. The market is expected to reach USD 5.4 billion by 2032. The demand for antiemetics drugs is expected to rise due to the increased rates of illnesses, including cancer and gastroenteritis, that cause nausea and vomiting. Nausea and vomiting have been reported as side effects of numerous cancer medicines and treatments, including chemotherapy and gastroenteritis treatments. Antiemetic medications help manage these adverse effects while receiving treatment. Therefore, demand is expected to increase as cancer and gastroenteritis become more common.
Antiemetic drugs are prescriptions that help avoid vomiting, nausea, and vertigo. Many conditions, such as vertigo and motion sickness, are treated with antiemetic drugs. Since patents no longer cover most medications, anti-emetics have a large volume market. Anti-emetics drugs are primarily concerned with creating generic medications despite scientific efforts to increase the efficacy of target site specificity. Additionally under investigation is the use of anti-emetics in oncological therapy. During chemotherapy-induced vomiting and the first trimester of pregnancy, antiemetic drugs are necessary. Antiemetic drugs are also used to treat food poisoning, toxins, and the adverse effects of other medications that produce nausea and vomiting. The demand is expected to rise due to the increased rates of illnesses, including cancer and gastroenteritis, that cause nausea and vomiting. Nausea and vomiting have been reported as side effects of numerous cancer medicines and treatments, including chemotherapy and gastroenteritis treatments. Antiemetic drugs help manage these adverse effects while receiving treatment. Therefore, demand is expected to increase as cancer and gastroenteritis become more common.
Get an overview of this study by requesting a free sample
In April 2022, For Gimoti (metoclopramide) nasal spray, the U.S. Food and Drug Administration (FDA) granted Evoke Pharma, Inc. new drug product exclusivity. Evoke has enjoyed exclusive marketing rights for three years from initial approval under the Hatch-Waxman Act to shield the product from competition from generic drugs. A strong antiemetic medication is metoclopramide, a dopamine antagonist.
In February 2022, The US FDA approved Barhemsys, a product of Acacia Pharmaceutical. Amisulpride, a dopamine agonist, is administered intravenously to treat postoperative nausea and vomiting in patients who did not improve when treated with an antiemetic of a different type. The business is getting ready to go commercial, and Barhemsys should be released in the second half of 2022.
Rising prevalence of cancer- The growing number of cancer patients will support the industry's expansion. The sector is expanding as a result of the rise in cardiovascular illnesses. Every year, cancer claims the lives of about 9–10 million individuals. The two most prevalent forms of cancer are lung and breast, and their incidence has sharply grown. In 2021, there were about 680,000 breast cancer deaths globally out of 2.3 million cases that were diagnosed. In a similar vein, the growing smoking tendency is contributing to an increase in lung cancer prevalence. A study found that 82 per cent of lung cancer cases are caused by smoking. One of the most popular cancer treatments is chemotherapy, and one of the most prevalent side effects is nausea and vomiting. Most applications for antiemetic drugs in the global market are related to chemotherapy. The increased use of chemotherapy is to blame for this.
Side effects of anti-emetics- Recognising that antiemetic drugs may have adverse effects is critical. Constipation, lightheadedness, and tiredness are typical adverse effects. These adverse effects may be disabling, particularly for those who need complicated medication schedules. The advantages of anti-emetics must be weighed against these possible disadvantages by patients and healthcare professionals.
Expanding surgical procedures- No matter how big or small the surgery, postoperative nausea and vomiting (PONV) is a common side effect. Effective anti-emetic medications are becoming more and more necessary to reduce the incidence of PONV as surgical procedures become more complex and widespread. There is a significant market need for anti-emetics due to increased surgical operations.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest region for the global antiemetics drugs market, with a 39.7% market revenue share in 2022.
The presence of major firms like Pfizer and GSk plc contributes to a larger revenue share of the region. Furthermore, the increasing number of antiemetics drug approvals in the area is expected to fuel regional expansion. For example, Ondansetron, a 5-HT3 antagonist licenced for use as an antiemetic in Canada, is described in an article published by the Canadian Institutes of Health Research in May 2022. This medication is used to treat postoperative and chemotherapy-related nausea and vomiting.
North America Region Antiemetics Drugs Market Share in 2022 - 39.7%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The drug type segment is divided into anticholinergics, neurokinin receptor antagonists, serotonin-receptor antagonists, dopamine receptor antagonists, and others. The serotonin-receptor antagonists segment dominated the market, with a market share of around 29% in 2022. The increased use of serotonin-receptor antagonist medications to prevent nausea and vomiting related to chemotherapy, radiation therapy, and anaesthesia, along with the rising global incidence of cancer, is responsible for the segment's larger revenue share and growth.
The application segment is divided into gastroenteritis, postoperative surgery, chemotherapy, and others. The chemotherapy segment dominated the market, with a market share of around 36% in 2022. The segment's larger revenue share can be attributed to the rising number of new product launches and the growing use of antiemetics to treat chemotherapy-related nausea and vomiting. For example, Helsinn, a Swiss pharmaceutical company, and Mundipharma launched the hard capsule AKYNZEO for oral use in Brazil in May 2018. This medication is used to treat acute and delayed chemotherapy-induced nausea and vomiting.
The end-user segment is divided into retail pharmacy, hospital & clinics, and others. The retail pharmacy segment dominated the market, with a market share of around 41% in 2022. Retail pharmacies' convenience and product availability are expected to fuel the segment's expansion. Throughout the projected period, it is also expected that numerous retail pharmacy chains worldwide, such as Rite Aid, Walgreens Boots Alliance, and CVS Pharmacy, will increase the demand for these medications.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2022 | USD 3.1 Billion |
Market size value in 2032 | USD 5.4 Billion |
CAGR (2023 to 2032) | 5.9% |
Historical data | 2019-2021 |
Base Year | 2022 |
Forecast | 2023-2032 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Drug Type, Application, End-User |
As per The Brainy Insights, the size of the antiemetics drugs market was valued at USD 3.1 billion in 2022 to USD 5.4 billion by 2032.
The global antiemetics drugs market is growing at a CAGR of 5.9% during the forecast period 2023-2032.
North America emerged as the largest antiemetics drugs market.
Key players in the antiemetics drugs market are Pfizer Inc, Johnson and Johnson Services Inc, Hikma Pharmaceuticals Plc, Novartis AG, Torrent Pharmaceuticals Ltd, GlaxoSmithKline Plc, Merck and Co Inc, Sanofi, Cipla Limited, and Baxter.
This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global antiemetics drugs market based on the below-mentioned segments:
Global Antiemetics Drugs Market By Drug Type:
Global Antiemetics Drugs Market By Application:
Global Antiemetics Drugs Market By End-User:
Global Antiemetics Drugs Market By Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date